Aspira Pathlab & Diagnostics Ltd.

31.00 -1.40 ▼-4.3%

26 May 2023, 04:01:00 PM
Volume: 312

Company Profile

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.aspiradiagnostics.com
Market Cap 31.91 Cr.
Enterprise Value(EV) 29.04 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.57 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 19.77 Trailing Twelve Months Ending 2022-12
Industry PE 49.39 Trailing Twelve Months Ending 2022-12
Book Value / Share 12.59 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.46 Calculated using Price: 31.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.03 Cr. 10,293,000 Shares
FaceValue 10
About Aspira Pathlab & Diagnostics Ltd.
The Company is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations.

Aspira Pathlab & Diagnostics Ltd. Delivery

Delivered Qty
Traded Qty

Aspira Pathlab & Diagnostics Ltd. Performance

1 Day
-4.32%
1 Week
-3.12%
1 Month
-5.17%
3 Month
-13.41%
6 Month
-27.65%
1 Year
-42.06%
2 Year
+3.68%
5 Year
+73.96%
10 Year

Aspira Pathlab & Diagnostics Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.55 1.10 0.76 -57.04 -178.61 -187.57 -94.32 22.80 42.26
Return on Capital Employed (%) 3.88 3.95 1.78 -25.35 -38.38 -34.50 -26.30 21.52 41.63
Return on Assets (%) 2.55 1.05 0.54 -25.76 -40.76 -37.93 -29.11 10.58 29.82

Aspira Pathlab & Diagnostics Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1 4 4 6 0 5 4 8 13 13
Non Curr. Liab. 3 11 5 5 1 4 3
Curr. Liab. 0 3 6 2 4 5 2 2 2
Minority Int.
Equity & Liab. 1 4 6 15 13 15 14 12 18 18
Non Curr. Assets 1 11 11 13 11 8 11 10
Curr. Assets 1 4 6 4 2 2 3 4 7 7
Misc. Exp. not W/O
Total Assets 1 4 6 15 13 15 14 12 18 18

Aspira Pathlab & Diagnostics Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1 4 8 8 15 20 16
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 1 5 8 9 15 20 17
Total Expenditure 0 0 0 -3 -8 -11 -10 -12 -13 -13
PBIDT 0 0 0 -2 -4 -3 -2 4 6 4
Interest 0 0 0 -1 -1 -1 -1 0 0
Depreciation 0 -1 -1 -2 -1 -2 -2
Taxation 0 0 0 0
Exceptional Items
PAT 0 0 0 -3 -6 -5 -4 1 4 2
Adjusted EPS 0 0 0 -5 -11 -6 -5 1 4 2

Aspira Pathlab & Diagnostics Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 -5 -3 -2 6 2
Cash Fr. Inv. 0 0 0 0 -10 -1 -2 0 0 -1
Cash Fr. Finan. 3 3 9 7 3 1 -2 -1
Net Change 0 0 3 2 -3 1 -2 0 3 0
Cash & Cash Eqvt 0 0 3 5 3 0 -2 -2 1 1

Aspira Pathlab & Diagnostics Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 36.25 36.25 36.25 36.25 36.25 36.19 34.55 19.48 19.47
Public 63.75 63.75 63.75 63.75 63.75 63.81 65.45 80.52 80.53
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Aspira Pathlab & Diagnostics Ltd. Announcements

Sat, 27 May 2023
Announcement Under Regulation 30 (LODR)-Appointment Of Secretarial Auditor And Internal Auditor
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held on Saturday May 27 2023 has approved the appointment of M/s. Nilesh A. Pradhan & Co. LLP Practicing Company Secretary as a Secretarial Auditor and M/s. Vishal Bhanushali & Associates Chartered Accountant as an Internal Auditor of the Company. The Information required to be submitted pursuant to Regulation 30 of the Listing Regulations is marked and attached as Annexure-A & B.
Sat, 27 May 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 27 May 2023
Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) the Board of Directors of the Company at their held on Saturday 27th May 2023 which was commenced at 03:30 P.M. and concluded at 05:20 PM. Attached Agenda items were approved in the meeting.
Sat, 27 May 2023
Financial Result For The Period Ended 31St March 2023
Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) this is to inform that Board of Directors of the Company in their meeting held today i.e. May 27 2023 has inter-alia considered and approved the Audited Financial Results for the year ended on March 31 2023.Please find attached:Audited Financial Results for the year ended on March 31 2023 along with statement of Assets & Liabilities and Cash Flow Statement Auditors Report and Declaration about unmodified opinion in audit report.

Aspira Pathlab & Diagnostics Ltd. Technical Scans

Fri, 26 May 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Aspira Pathlab & Diagnostics Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Aspira Pathlab & Diagnostics Ltd. FAQ's

What is Aspira Pathlab&Diagn share price?

Can I buy Aspira Pathlab&Diagn shares now?

What is the Market Cap of Aspira Pathlab&Diagn?

What are the key metrics to analyse Aspira Pathlab&Diagn?

What is the 52 Week High and Low of Aspira Pathlab&Diagn?

What is the trend of Aspira Pathlab&Diagn share price?